Tanvex BioPharma Inc
TWSE:6541

Watchlist Manager
Tanvex BioPharma Inc Logo
Tanvex BioPharma Inc
TWSE:6541
Watchlist
Price: 68.2 TWD 0.89% Market Closed
Market Cap: 11.2B TWD
Have any thoughts about
Tanvex BioPharma Inc?
Write Note

Tanvex BioPharma Inc
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tanvex BioPharma Inc
Current Portion of Long-Term Debt Peer Comparison

Comparables:
688235
6550

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Tanvex BioPharma Inc
TWSE:6541
Current Portion of Long-Term Debt
NT$171.2m
CAGR 3-Years
33%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Beigene Ltd
SSE:688235
Current Portion of Long-Term Debt
ÂĄ358.8m
CAGR 3-Years
57%
CAGR 5-Years
43%
CAGR 10-Years
N/A
Polaris Group
TWSE:6550
Current Portion of Long-Term Debt
NT$71.5m
CAGR 3-Years
-19%
CAGR 5-Years
-30%
CAGR 10-Years
N/A

See Also

What is Tanvex BioPharma Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
171.2m TWD

Based on the financial report for Jun 30, 2024, Tanvex BioPharma Inc's Current Portion of Long-Term Debt amounts to 171.2m TWD.

What is Tanvex BioPharma Inc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
19%

Over the last year, the Current Portion of Long-Term Debt growth was 14%. The average annual Current Portion of Long-Term Debt growth rates for Tanvex BioPharma Inc have been 33% over the past three years , 19% over the past five years .

Back to Top